Panacea Biotec Limited has informed the Exchange about change in Management
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has informed the stock exchanges that Mr. Sunil Anand, Associate Director – Finance & Corporate Affairs and Senior Management Personnel, retired from the company on March 31, 2025 after serving for over two decades in roles including Whole-time Director and Associate Director. The change is due to superannuation (retirement), so no resignation letter was required. The company has expressed appreciation for his long contribution to business growth. The disclosure is filed under Regulation 30 of SEBI LODR Regulations.
This is a planned, orderly retirement of a long-serving senior manager and is unlikely to materially affect the stock. Shareholders may want to watch for clarity on succession planning for the Finance & Corporate Affairs function going forward.